Bristol Myers Squibb has chosen Houston, Texas, as the site for a new manufacturing campus, representing an approximately $2.3 billion investment.
The company said the campus, at Generation Park in Houston, will create nearly 500 jobs and is designed to grow in scale.
Bristol Myers Squibb’s approximately 600,000-square-foot manufacturing campus in Houston will be a modular, multi-modal campus designed for flexibility and long-term growth. Its architecture allows new manufacturing capabilities to be brought online rapidly. The campus is also built for adaptability, with configuration flexibility that anticipates future advances in digital integration and automation, ensuring the site remains at the frontier of biopharmaceutical development and manufacturing technology as capabilities continue to evolve. BMS envisions this site growing in scale and capability well beyond its opening configuration.
BMS also expects to create approximately 2,000 construction and other indirect jobs between 2027–2030 as the facility is built and brought online.
The company said it will continue to build and grow its commitment to Texas. The company currently works with a contract manufacturer in Texas for both commercial and clinical trial manufacturing and, in 2025, had 250 clinical trial sites throughout the state to advance clinical research across its portfolio.
